1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
(
- Contribution to journal › Article
- 2020
-
Mark
Calcein release assay as a method for monitoring serum complement activity during monoclonal antibody therapy in patients with B-cell malignancies
(
- Contribution to journal › Article
-
Mark
Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
(
- Contribution to journal › Article
- 2018
-
Mark
Overactivity of alternative pathway convertases in patients with complement-mediated renal diseases
(
- Contribution to journal › Article
- 2017
-
Mark
Factor I
2017) p.147-154(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
C4b-Binding Protein
2017) p.251-259(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
New perspectives on complement mediated immunotherapy
(
- Contribution to journal › Scientific review
-
Mark
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
(
- Contribution to journal › Article
-
Mark
Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis
(
- Contribution to journal › Article